title: [The significance of antibiotic-hypersensitivity syndrome].
authors.forename: Olatz
authors.initials: O
authors.lastname: Urbina
authors.forename: Olivia
authors.initials: O
authors.lastname: Ferrández
authors.forename: Mercè
authors.initials: M
authors.lastname: Espona
authors.forename: Santiago
authors.initials: S
authors.lastname: Grau
mesh_terms: D000081:Acetamides / Q000008:administration & dosage / Q000627:therapeutic use; D000368:Aged; D000741:Anemia, Aplastic / Q000097:blood / Q000139:chemically induced*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001922:Brain Abscess / Q000188:drug therapy* / Q000382:microbiology; D002443:Ceftriaxone / Q000008:administration & dosage / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D003221:Confusion / Q000209:etiology; D003875:Drug Eruptions / Q000175:diagnosis / Q000209:etiology*; D004359:Drug Therapy, Combination; D006801:Humans; D016867:Immunocompromised Host; D000069349:Linezolid; D008297:Male; D009157:Myasthenia Gravis / Q000150:complications / Q000188:drug therapy / Q000276:immunology; D009617:Nocardia Infections / Q000188:drug therapy*; D023303:Oxazolidinones / Q000008:administration & dosage / Q000627:therapeutic use; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000081:Acetamides; D000900:Anti-Bacterial Agents; D023303:Oxazolidinones; D002443:Ceftriaxone; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D000069349:Linezolid; D011241:Prednisone